Skip to main content Back to Top
Advertisement

5/1/2019

Polyvinyl Alcohol (Artificial Tears) Ophthalmic Solution

Products Affected - Description

    • Artificial Tears Solution ophthalmic solution, Akorn, 1.4%, 15 mL bottle, 1 count, NDC 17478-0060-12
    • Liquitears ophthalmic solution, Major, 1.4%, 15 mL bottle, 1 count, NDC 00904-6492-35

Reason for the Shortage

    • Akorn did not provide a reason for the shortage.
    • Altaire is not currently marketing polyvinyl alcohol 1.4% ophthalmic solution.
    • Major did not provide a reason for the Liquitears shortage.
    • Ocusoft has polyvinyl alcohol 1.4% ophthalmic solution available.
    • Rugby has polyvinyl alcohol 1.4% ophthalmic solution available.

Available Products

    • Artificial Tears ophthalmic solution, Rugby Laboratories, 1.4%, 15 mL bottle, 1 count, NDC 00536-1084-94
    • Tears Again ophthalmic solution, OCuSOFT, 1.4%, 15 mL bottle, 1 count, NDC 54799-0904-15
    • Tears Again ophthalmic solution, OCuSOFT, 1.4%, 30 mL bottle, 1 count, NDC 54799-0904-30

Estimated Resupply Dates

    • Akorn has Artificial Tears Solution ophthalmic drops on allocation.
    • Major has Liquitears ophthalmic drops on back order and the company cannot estimate a release date.

Updated

Updated May 1, 2019 by Leslie Jensen, PharmD, Drug Information Specialist. Created August 9, 2018 by Leslie Jensen, PharmD, Drug Information Specialist. © 2019, Drug Information Service, University of Utah, Salt Lake City, UT.

Disclaimer

This information is provided through the support of Vizient to ASHP solely as a service to its members, which shall not use this information for their further commercial use. The content was prepared by the Drug Information Center of University of Utah. Vizient, ASHP, and the University of Utah make no representations or warranties, express or implied, including, but not limited to, any implied warranty of merchantability and/or fitness for a particular purpose, which respect to such information, and specifically disclaim all such warranties. Users of this information are advised that decisions regarding the use of drugs and drug therapies are complex medical decisions and that in using this information, each user must exercise his or her own independent professional judgment. Neither Vizient, ASHP nor the University of Utah assumes any liability for persons administering or receiving drugs or other medical care in reliance upon this information, or otherwise in connection with this bulletin. Neither Vizient, ASHP nor University of Utah endorses or recommends the use of any drug.

« Back to Drug Shortage Product Bulletins